Ragweed Allergy Nasal Spray Study

Cliantha Research, Patient Recruitment


The purpose of this study is to assess the onset of effectiveness of a nasal spray (marketed in the USA) in treating allergy symptoms caused by ragweed pollen in an Environmental Exposure Chamber (EEC) compared to a placebo. Study Ref: 19-SB-001.

Eligibility Criteria


Male, Female

18 to 65 years old

allergic rhinitis to ragweed for at least the last 2 years

If smoker, cannot smoke more than 26 cigarettes per day

Cannot be symptomatic to dust mites/mold

Study Tasks


Informed Consent Form
Vital signs
Demographics
Medical/Surgical history
Review of prior/concomitant medications
Skin Prick Test

Ethics


This study has been approved by Advarra Ethics Board.

Keywords


Ragweed allergy
clinical research
nasal symptoms

Activity and Time


Investigational Medicine

Clinical Trial

Weekdays, Weekends

4 hour(s) - 9.5 hour(s) per session

6 session(s)

Up to 6 visits (including medical screening and follow-up visit)

Compensation


Up to $2300 

Study Address


4500 Dixie Road Mississauga, Ontario, Canada, L4W 1V7

Posting date: Jan 7, 2020

Earn $2300